Allergy Therapeutics to sniff out more M&A deals - Manuel Llobert, CEO, Allergy Therapeutics 00:00:00
Manuel Llobert, chief executive of Allergy Therapeutics says firm the is far better placed to make acquisitions given the recent increase in its market value.